LEHI, UT, and SOUTH SAN FRANCISCO, CA – March 16, 2022—Lumea, the global leader in integrated digital pathology solutions and Verily, an Alphabet precision health company, today announced a strategic…
Read More
The groundbreaking Lumea BxChip® is now available in select European markets. An article in the American Journal of Clinical Pathology recently praised the chip's ability to reduce cost and increase the efficiency of...
Read More
Learn how labs are using the Lumea BxChip® to save lab time, increase efficiency, reduce costs, and improve quality for potentially better diagnostic accuracy. Two recent articles praise the BxChip…
OREM, Utah (PRWEB) February 14, 2018 — Accelerating the development of new digital cancer diagnostics in pathology is the aim of a new partnership between diagnostics pioneer Lumea and Southern…
